Dr Alistair Vickery

Medically prescribed products containing THC have shown value and safety in the management of a number of important clinical conditions, including debilitating chronic pain. Emyria who have seen over 3500 patients upholds evidence-based investigation and pharmacovigilance. Many patients are unfairly prohibited from access to these products by out-of-date driving legislation and testing that is not evidence-based. We need to Drive Change to prohibit driving with impairment, not driving with improvement.

Medical Director: Emerald Clinics

Reform for Roadside Drug Testing in NSW

This report provides an overview of recent data provided to the Legislative Council by the Minister for Police and Counter-terrorism in New South Wales on 10 September 2024, with regards to roadside drug tests conducted over the last 5 years (by Local Area Command), number of positives by drug type and whether there has been […]

It’s time to be kind and drive change for medicinal cannabis

Imagine having to choose between taking your legally prescribed medication and going to work,doing the school run or getting the shopping that week. Yes, week. This is the stark reality for many Australian medicinal cannabis patients because of the discriminatory drug-driving laws that still exist in most states. Current laws penalise the mere presence of […]